BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 19675861)

  • 1. Semi-quantitative analysis of perfusion of Brodmann areas in the differential diagnosis of cognitive impairment in Alzheimer's disease, fronto-temporal dementia and mild cognitive impairment.
    Tranfaglia C; Palumbo B; Siepi D; Sinzinger H; Parnetti L
    Hell J Nucl Med; 2009; 12(2):110-4. PubMed ID: 19675861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Voxel-based comparison of rCBF SPET images in frontotemporal dementia and Alzheimer's disease highlights the involvement of different cortical networks.
    Varrone A; Pappatà S; Caracò C; Soricelli A; Milan G; Quarantelli M; Alfano B; Postiglione A; Salvatore M
    Eur J Nucl Med Mol Imaging; 2002 Nov; 29(11):1447-54. PubMed ID: 12397463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eating Disorders in Frontotemporal Dementia and Alzheimer's Disease: Evaluation of Brain Perfusion Correlates Using 99mTc-HMPAO SPECT with Brodmann Areas Analysis.
    Valotassiou V; Sifakis N; Tzavara C; Lykou E; Tsinia N; Kamtsadeli V; Sali D; Angelidis G; Psimadas D; Tsougos I; Papageorgiou SG; Georgoulias P; Papatriantafyllou J
    J Alzheimers Dis; 2021; 80(4):1657-1667. PubMed ID: 33720894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of (99m)Tc-HMPAO SPET changes in dementia with Lewy bodies and Alzheimer's disease using statistical parametric mapping.
    Colloby SJ; Fenwick JD; Williams ED; Paling SM; Lobotesis K; Ballard C; McKeith I; O'Brien JT
    Eur J Nucl Med Mol Imaging; 2002 May; 29(5):615-22. PubMed ID: 11976799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional cerebral blood flow assessed with 99mTc-ECD SPET as a marker of progression of mild cognitive impairment to Alzheimer's disease.
    Encinas M; De Juan R; Marcos A; Gil P; Barabash A; Fernández C; De Ugarte C; Cabranes JA
    Eur J Nucl Med Mol Imaging; 2003 Nov; 30(11):1473-80. PubMed ID: 14579086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain perfusion SPECT in patients with mild cognitive impairment and Alzheimer's disease: comparison of a semiquantitative and a visual evaluation.
    Staffen W; Schönauer U; Zauner H; Spindler I; Mair A; Iglseder B; Bernroider G; Ladurner G
    J Neural Transm (Vienna); 2006 Feb; 113(2):195-203. PubMed ID: 15959843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and APO E4 medial temporal lobe dementias. The Oxford Project to Investigate Memory and Aging.
    Jobst KA; Barnetson LP; Shepstone BJ
    Int Psychogeriatr; 1997; 9 Suppl 1():191-222; discussion 247-52. PubMed ID: 9447442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional cerebral blood flow differences in patients with mild cognitive impairment between those who did and did not develop Alzheimer's disease.
    Park KW; Yoon HJ; Kang DY; Kim BC; Kim S; Kim JW
    Psychiatry Res; 2012; 203(2-3):201-6. PubMed ID: 22980226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience.
    Johnson NA; Jahng GH; Weiner MW; Miller BL; Chui HC; Jagust WJ; Gorno-Tempini ML; Schuff N
    Radiology; 2005 Mar; 234(3):851-9. PubMed ID: 15734937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Molecular neuroimaging in the study of cognitive impairment: contribution of the cerebral blood flow SPECT with 99mTc-HMPAO and 18F-FDG PET/CT scan].
    Banzo I; Quirce R; Martínez-Rodríguez I; Jiménez-Bonilla J; Portilla-Quattrociocchi H; Medina-Quiroz P; Ortega F; Rodríguez E; Mateo I; Vázquez-Higuera JL; de Arcocha M; Carril JM
    Rev Esp Med Nucl; 2011; 30(5):301-6. PubMed ID: 21640440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences of apathy perfusion correlates between Alzheimer's disease and frontotemporal dementia. A 99mTc-HMPAO SPECT study with automated Brodmann areas analysis.
    Valotassiou V; Sifakis N; Tzavara C; Lykou E; Tsinia N; Kamtsadeli V; Sali D; Angelidis G; Psimadas D; Tsougos I; Papageorgiou SG; Georgoulias P; Papatriantafyllou J
    Int J Psychiatry Clin Pract; 2022 Mar; 26(1):14-22. PubMed ID: 33207961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined magnetic resonance imaging and single-photon emission tomography scanning in the discrimination of Alzheimer's disease from age-matched controls.
    O'Brien JT; Ames D; Desmond P; Lichtenstein M; Binns D; Schweitzer I; Davis S; Tress B
    Int Psychogeriatr; 2001 Jun; 13(2):149-61. PubMed ID: 11495391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebral perfusion (HMPAO-SPECT) in patients with depression with cognitive impairment versus those with mild cognitive impairment and dementia of Alzheimer's type: a semiquantitative and automated evaluation.
    Staffen W; Bergmann J; Schönauer U; Zauner H; Kronbichler M; Golaszewski S; Ladurner G
    Eur J Nucl Med Mol Imaging; 2009 May; 36(5):801-10. PubMed ID: 19137294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perfusion SPECT studies with mapping of Brodmann areas in differentiating Alzheimer's disease from frontotemporal degeneration syndromes.
    Valotassiou V; Papatriantafyllou J; Sifakis N; Tzavara C; Tsougos I; Kapsalaki E; Hadjigeorgiou G; Georgoulias P
    Nucl Med Commun; 2012 Dec; 33(12):1267-76. PubMed ID: 23018627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic value of FDG-PET and HMPAO-SPET in patients with mild dementia and mild cognitive impairment: metabolic index and perfusion index.
    Döbert N; Pantel J; Frölich L; Hamscho N; Menzel C; Grünwald F
    Dement Geriatr Cogn Disord; 2005; 20(2-3):63-70. PubMed ID: 15908747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new approach for improving diagnostic accuracy in Alzheimer's disease and frontal lobe dementia utilising the intrinsic properties of the SPET dataset.
    Pagani M; Kovalev VA; Lundqvist R; Jacobsson H; Larsson SA; Thurfjell L
    Eur J Nucl Med Mol Imaging; 2003 Nov; 30(11):1481-8. PubMed ID: 14579087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain SPECT in subtypes of mild cognitive impairment. Findings from the DESCRIPA multicenter study.
    Nobili F; Frisoni GB; Portet F; Verhey F; Rodriguez G; Caroli A; Touchon J; Calvini P; Morbelli S; De Carli F; Guerra UP; Van de Pol LA; Visser PJ
    J Neurol; 2008 Sep; 255(9):1344-53. PubMed ID: 18958573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Posterior cingulate hypoperfusion in Alzheimer's disease, senile dementia of Alzheimer type, and other dementias evaluated by three-dimensional stereotactic surface projections using Tc-99m HMPAO SPECT.
    Kaneko K; Kuwabara Y; Sasaki M; Ogomori K; Ichimiya A; Koga H; Nakagawa M; Hayashi K; Honda H
    Clin Nucl Med; 2004 Jun; 29(6):362-6. PubMed ID: 15166883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A region-of-interest template for three-dimensional stereotactic surface projection images: initial application to the analysis of Alzheimer's disease and mild cognitive impairment.
    Kubota T; Ushijima Y; Okuyama C; Nishimura T
    Nucl Med Commun; 2006 Jan; 27(1):37-44. PubMed ID: 16340722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concordance between (99m)Tc-ECD SPECT and 18F-FDG PET interpretations in patients with cognitive disorders diagnosed according to NIA-AA criteria.
    Ito K; Shimano Y; Imabayashi E; Nakata Y; Omachi Y; Sato N; Arima K; Matsuda H
    Int J Geriatr Psychiatry; 2014 Oct; 29(10):1079-86. PubMed ID: 24687634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.